Financhill
Buy
57

NOVT Quote, Financials, Valuation and Earnings

Last price:
$124.07
Seasonality move :
-0.9%
Day range:
$123.18 - $124.62
52-week range:
$98.76 - $187.12
Dividend yield:
0%
P/E ratio:
63.43x
P/S ratio:
4.72x
P/B ratio:
5.81x
Volume:
183.1K
Avg. volume:
289.9K
1-year change:
-21.39%
Market cap:
$4.5B
Revenue:
$949.2M
EPS (TTM):
$1.96

Earnings Data

Next earnings date for NOVT
Aug 06
2025
Most recent earnings per share
$0.59
Missed by $0.08
(May 6/2025)
Consensus Estimate
$0.67
(May 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

NOVT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/06/2025 Q2 $238M -- -- $0.73 --
05/06/2025 Q1 $233.3M $233.4M $0.59 $0.67 -$0.08
02/25/2025 Q4 $240.3M $238.1M $0.46 $0.71 -$0.25
11/05/2024 Q3 $242.3M $244.4M $0.53 $0.85 -$0.32
08/06/2024 Q2 $233.6M $235.9M $0.38 $0.69 -$0.31
05/07/2024 Q1 $227.9M $230.9M $0.41 $0.58 -$0.17
02/28/2024 Q4 $210.5M $211.6M $0.34 $0.64 -$0.30
11/07/2023 Q3 -- -- $0.59 $0.74 -$0.15
08/08/2023 Q2 -- -- $0.58 $0.73 -$0.15
05/09/2023 Q1 -- -- $0.51 $0.64 -$0.13
03/01/2023 Q4 -- -- $0.42 $0.72 -$0.30
11/08/2022 Q3 -- -- $0.63 $0.74 -$0.11
08/09/2022 Q2 -- -- $0.49 $0.72 -$0.23
05/10/2022 Q1 -- -- $0.53 $0.63 -$0.10
03/01/2022 Q4 -- -- $0.38 $0.64 -$0.26
11/09/2021 Q3 -- -- $0.38 $0.60 -$0.22
08/10/2021 Q2 -- -- $0.33 $0.51 -$0.18
05/11/2021 Q1 -- -- $0.32 $0.39 -$0.07
03/01/2021 Q4 -- -- $0.35 $0.44 -$0.09
11/10/2020 Q3 -- -- $0.23 $0.39 -$0.16
08/06/2020 Q2 -- -- $0.33 $0.23 $0.10
05/12/2020 Q1 -- -- $0.34 $0.32 $0.02
02/26/2020 Q4 -- -- $0.26 $0.54 -$0.28
11/05/2019 Q3 -- -- $0.25 $0.52 -$0.27
08/06/2019 Q2 -- -- $0.29 $0.54 -$0.25
05/07/2019 Q1 -- -- $0.35 $0.48 -$0.13
02/27/2019 Q4 -- -- $0.33 $0.51 -$0.18
11/06/2018 Q3 -- -- $0.60 $0.52 $0.08
08/08/2018 Q2 -- -- $0.32 -- --
05/08/2018 Q1 -- -- $0.18 -- --
02/28/2018 Q4 -- -- -$0.00 -- --
11/01/2017 Q3 -- -- -$0.00 -- --
08/03/2017 Q2 -- -- $0.16 -- --
05/08/2017 Q1 -- -- $0.98 -- --
02/06/2017 Q4 -- -- $0.22 -- --
11/02/2016 Q3 -- -- $0.21 -- --
08/02/2016 Q2 -- -- $0.14 -- --
05/06/2016 Q1 -- -- $0.05 -- --
03/02/2016 Q4 -- -- $0.18 -- --
11/04/2015 Q3 -- -- $0.19 -- --
08/05/2015 Q2 -- -- $0.56 -- --

Novanta Earnings Questions

  • How Much did Novanta Generate in Revenue Last Quarter?

    Novanta reported $233.4M worth of top line sales in its most recent quarter.

  • Did Novanta Beat Earnings Last Quarter?

    Novanta announced earnings per share of $0.59 which represents a miss of analyst forecast a $0.67 per share.

  • Is Novanta Profitable?

    Novanta reported $104.4M that represents $2.89 per share over the last quarter.

  • What is the Analyst Consensus for Novanta EPS Next Year?

    Novanta's earnings are forecast to grow from $1.77 per share to $3.03 per share next year representing an increase of 90.4%.

  • When is Novanta's Earnings Date?

    Novanta's next earnings date is August 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Dell Stock Be in 5 Years?
Where Will Dell Stock Be in 5 Years?

So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…

Where Will Cameco Stock Be in 5 Years?
Where Will Cameco Stock Be in 5 Years?

Cameco (NYSE: CCJ) isn’t exactly the kind of stock you…

Microsoft Stock Outlook, Azure & AI as Drivers of Long-Term Growth
Microsoft Stock Outlook, Azure & AI as Drivers of Long-Term Growth

Microsoft (NASDAQ:MSFT) has been among the top growth stocks of…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
70
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 47x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
84
SBET alert for May 30

SharpLink Gaming [SBET] is down 3.17% over the past day.

Buy
55
RGC alert for May 30

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Buy
73
CTEV alert for May 30

Claritev [CTEV] is up 7.82% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock